000 04208nas a2200421 a 4500
005 20260818095357.0
008 080901s2008 th uu|m rtt 0| a1eng d
035 _a.b12038635
099 9 _aAIT Thesis no.EV-08-45
100 0 _aWatanyoo Nakareangrit
245 1 4 _aThe efficiency of andrographolide in attenuating cadmium-induced hepatotoxicity in rats
260 _aPathum Thani, Thailand :
_bAsian Institute of Technology,
_c2008
300 _a39 leaves :
_bill. +
_e1 online resource
490 1 _aThesis ;
_vno. EV-08-45
500 _aA thesis sub mitted in partial fulfillment of the requirements for the degree of Master of Science in Environmental Engineering and Management Inter-University Program on Environmental Toxicology, Technology and Management
502 _aThesis (M.Sc.) - Asian Institute of Technology - Chulabhorn Research Institute - Mahidol University, 2008
520 _aThe aim of this study was to determine the efficiency of andrographolide (AP) in attenuating cadmium-induced hepatotoxicity in rats in comparison with silymarin (SL), a standard hepatoprotective agent. Rats were treated with CdCl₂ at doses of 0.75, 1.0 mg/kg, intraperitoneal injection (i.p.), for 14 days. For the next 7 days, rats were given oral doses of AP at 6 (AP6), 60 (AP60) mg/kg, and SL at 60 (SL60) mg/kg. The significant decrease of body weight was observed in all Cd-treated rats during the first 14 days and then increased gradually during the drug treatments. Intraperitoneal injection of CdCl₂ had higher levels of cadmium accumulated in liver than kidney. Moreover, Cadmium accumulation also increased in lung, brain and testis of cadmium-treated rats. In Cd0.75-treated group, AP60 significantly decreased Cd accumulation in kidney while this effect was not significant in liver. However, in the Cd1.0-treated group, AP60 and SL60 significantly decreased Cd accumulation in liver. In addition, these drug treatments (AP60 and SL60) could also decrease Cd accumulation in kidney. Administration of AP60 and SL60 may possibly increase cadmium excretion resulting in the reduction of cadmium accumulation in liver and kidney of cadmium-treated rats. All Cd-treated rats showed histopathological changes in liver. The results from liver function test showed that alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities of Cd1.0-treated rats increased significantly. Both AP and SL at 60 mg/kg seemed to decrease these liver enzyme activities induced by cadmium whereas AP at 6 mg/kg did not show this effect. Post-treatment of AP and SL (60 mg/kg) for 7 days was found to attenuate hepatotoxicity induced by CdCl₂. However, AP at the dose 6 mg/kg had no hepatoprotective effect on cadmium-induced hepatic damage. The present results indicated that AP60 is as potent as SL60 for the treatment of hepatotoxicity induced by cadmium. Therefore, AP may have the potential to be used as a hepatoprotective drug against Cd-induced toxicity
650 0 _aCadmium
650 0 _aHepatotoxicology
700 0 _aJutamaad Satayavivad,
_eChairperson
700 0 _aPreeda Pakpian,
_eExamination Committee
700 0 _aNuchanart Rangkadilok,
_eExamination committee
710 2 _aThailand (HM Queen),
_eScholarship donor
810 2 _aAsian Institute of Technology.
_tThesis ;
_vno. EV-08-45
856 _3Full-Text
_uhttp://203.159.5.9/ait-thesis/detail.php?q=B02433
907 _a.b12038635
_bmnait
_cu
902 _a240401
998 _b0
_c080901
_dm
_ea
_fu
_g4
945 _lmnait
945 _lmnait
945 _lmnarc
942 _c20
942 _c40
909 _aBarcode : 30050120736938
_bCREATED : 2007-04-04
_cRECORD # : i12571477
_dLPATRON : 1015494
_eLCHKIN : 2015-04-02
_f# RENEWALS : 0
_g# OVERDUE : 0
_hIUSE3 : 0
_iTOT CHKOUT : 1
_jTOT RENEW : 0
909 _aBarcode : 30050120736904
_bCREATED : 2007-04-04
_cRECORD # : i12571489
_dLPATRON : 0
_eLCHKIN : -
_f# RENEWALS : 0
_g# OVERDUE : 0
_hIUSE3 : 0
_iTOT CHKOUT : 0
_jTOT RENEW : 0
909 _aBarcode : 30050160048855
_bCREATED : 2016-05-31
_cRECORD # : i13006058
_dLPATRON : 0
_eLCHKIN : -
_f# RENEWALS : 0
_g# OVERDUE : 0
_hIUSE3 : 0
_iTOT CHKOUT : 0
_jTOT RENEW : 0
999 _c35530
_d35530